2'3'-cGAMP (Sodium Salt): Precision STING Agonist for Innate Immunity Research

Executive Summary: 2'3'-cGAMP (sodium salt) is an endogenous cyclic dinucleotide, produced by mammalian cGAS in response to cytosolic double-stranded DNA, directly activating STING with high affinity (Kd = 3.79 nM) and triggering type I interferon induction (JCI, 2025). It is highly water-soluble (≥7.56 mg/mL), chemically stable at -20°C, and is the gold-standard tool for dissecting cGAS-STING signaling in cancer immunotherapy and antiviral studies (APExBIO, B8362). Recent research demonstrates its pivotal role in normalizing tumor vasculature and promoting CD8+ T cell infiltration. This article benchmarks 2'3'-cGAMP against other STING agonists, clarifies practical limitations, and provides parameters for effective laboratory integration.

Biological Rationale

2'3'-cGAMP is a cyclic dinucleotide second messenger endogenously synthesized by cyclic GMP-AMP synthase (cGAS) upon detection of cytosolic double-stranded DNA [1]. This molecule directly binds and activates the stimulator of interferon genes (STING) protein, a central adaptor in the innate immune response. Activation of STING leads to downstream signaling involving TANK-binding kinase 1 (TBK1) and interferon regulatory factor 3 (IRF3), culminating in the production of type I interferons (e.g., IFN-β). Type I interferons are essential for linking innate and adaptive immunity, enhancing antigen presentation, and promoting anti-tumor and antiviral responses. Dysregulation of this pathway is implicated in chronic inflammation, autoimmunity, and cancer progression [1].

Mechanism of Action of 2'3'-cGAMP (sodium salt)

Upon generation by cGAS, 2'3'-cGAMP binds to the CDN binding domain of STING, which resides in the endoplasmic reticulum membrane. The binding affinity (Kd) of 2'3'-cGAMP to STING is 3.79 nM, surpassing that of other cyclic dinucleotides [B8362 datasheet]. Ligand binding induces a conformational change in STING, facilitating its translocation from the ER to the Golgi apparatus. Here, STING undergoes palmitoylation at cysteine residues 88 and 91, which is required for downstream signaling. STING then recruits TBK1 and IRF3, resulting in their phosphorylation and subsequent activation of type I IFN transcription. In endothelial cells, STING also interacts with JAK1 following IFN-I stimulation, promoting vessel normalization and CD8+ T cell infiltration in the tumor microenvironment [1].

Evidence & Benchmarks

• 2'3'-cGAMP (sodium salt) binds human STING with a dissociation constant (Kd) of 3.79 nM (B8362 product documentation: APExBIO).
• Endothelial STING activation by 2'3'-cGAMP leads to tumor vessel normalization and increased CD8+ T cell infiltration (Zhang et al., 2025, DOI).
• STING agonists such as 2'3'-cGAMP are essential for robust induction of type I IFN signaling, critical for antitumor immunity (Zhang et al., 2025, DOI).
• 2'3'-cGAMP is highly water-soluble (≥7.56 mg/mL) but insoluble in ethanol and DMSO (B8362 datasheet: APExBIO).
• Storage at -20°C preserves chemical stability for extended periods (APExBIO).
• In translational research, 2'3'-cGAMP outperforms alternative STING agonists regarding reproducibility and specificity (internal review).

This article extends the discussion in [LB Agar Miller] by providing updated mechanistic data and benchmarking in clinical tumor models. It also clarifies translational applications beyond those reviewed in [Oprozomib ONX-0912], focusing on workflow integration and pitfalls.

Applications, Limits & Misconceptions

2'3'-cGAMP (sodium salt) is used in:

• Cancer Immunotherapy Research: Enables precise dissection of cGAS-STING-dependent antitumor responses, including vascular normalization and CD8+ T cell recruitment [1].
• Antiviral Innate Immunity: Serves as a model agonist for studying type I interferon induction in response to viral DNA [internal].
• Drug Screening: Used as a reference compound for screening and benchmarking novel STING-targeted drugs [B8362].
• Basic Immunology: Facilitates mechanistic studies of innate immune signaling in various cell types, including dendritic cells, macrophages, and endothelial cells [internal].

Common Pitfalls or Misconceptions

• Solvent Choice: 2'3'-cGAMP (sodium salt) is insoluble in ethanol and DMSO; use only aqueous buffers for dissolution (APExBIO).
• Cell Type Specificity: Not all cell types respond equally; some tumor cells lack functional STING expression and may not respond to 2'3'-cGAMP [1].
• Chronic Exposure: Prolonged activation of STING can drive chronic inflammation or cellular senescence [1].
• Species Differences: Human and murine STING show distinct ligand specificities; confirm cross-species compatibility for translational studies.
• Overinterpretation: 2'3'-cGAMP does not activate interferon pathways in the absence of STING; negative results may indicate pathway defects, not compound inactivity.

Workflow Integration & Parameters

2'3'-cGAMP (sodium salt) is typically supplied as a solid, with molecular formula C20H22N10Na2O13P2 and molecular weight 718.37 Da. Reconstitute in sterile water to a concentration of ≥7.56 mg/mL. Store aliquots at -20°C to ensure long-term stability. For in vitro experiments, use concentrations ranging from 0.1 μM to 10 μM, depending on cell type and experimental endpoint. For in vivo studies, dosing regimens vary; consult recent literature for species- and model-specific guidelines [1]. Always include appropriate negative and positive controls, and validate STING pathway integrity in recipient cells prior to use. The B8362 kit from APExBIO provides batch-tested, research-grade material for reproducible results [B8362].

Conclusion & Outlook

2'3'-cGAMP (sodium salt) represents a benchmark STING agonist, enabling robust and reproducible interrogation of cGAS-STING signaling in cancer and antiviral research. Its high specificity, superior affinity, and validated performance in translational models make it a preferred choice for immunology and drug discovery workflows. However, practitioners should be aware of cell-type specificity, solvent limitations, and the risks of chronic pathway activation. Ongoing research continues to illuminate new cell-specific roles for STING, such as endothelial JAK1-STAT axis modulation, with implications for next-generation immunotherapies [1]. For technical details and ordering, refer to the 2'3'-cGAMP (sodium salt) product page. For advanced workflows and troubleshooting, see our contrast with this internal protocol guide, which this article updates with data from recent tumor vasculature studies.